We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
Cap. Flow
+$2.33B
Cap. Flow %
4.39%
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7 quarters
Top 10 Avg Time Held
6.6 quarters
Top 20 Avg Time Held
9.9 quarters

Top Buys

Rank Stock Value
1
ZS icon
Zscaler
ZS
+$222M
2
PLTR icon
Palantir
PLTR
+$221M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$213M
4
FE icon
FirstEnergy
FE
+$189M
5
AVGO icon
Broadcom
AVGO
+$174M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$383M
2
PM icon
Philip Morris
PM
+$280M
3
ETR icon
Entergy
ETR
+$207M
4
PAYX icon
Paychex
PAYX
+$206M
5
GILD icon
Gilead Sciences
GILD
+$201M

Sector Composition

Rank Sector Weight
1 Technology 22.81%
2 Healthcare 14.57%
3 Financials 13.43%
4 Industrials 10.29%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GH icon
176
Guardant Health
GH
$22.5B
$76.3M 0.14%
1,465,438
+615,429
+72% +$27.5M
2020 Q2
20 quarters
ABT icon
177
Abbott
ABT
$172B
$76.1M 0.14%
559,854
-98,398
-15% -$13M
2013 Q2
48 quarters
DKNG icon
178
DraftKings
DKNG
$9.72B
$75.3M 0.14%
1,755,383
-101,817
-5% -$3.65M
2023 Q1
9 quarters
TCOM icon
179
Trip.com Group
TCOM
$24.5B
$74.7M 0.14%
1,273,369
+398,470
+46% +$23.9M
2020 Q3
19 quarters
RARE icon
180
Ultragenyx Pharmaceutical
RARE
$1.53B
$74.5M 0.14%
2,049,501
-5,699
-0.3% -$205K
2014 Q1
45 quarters
ATYR icon
181
aTyr Pharma
ATYR
$24.1M
$74.4M 0.14%
14,666,600
– –
2019 Q2
24 quarters
WTFC icon
182
Wintrust Financial
WTFC
$9.66B
$74.1M 0.14%
597,769
-171,755
-22% -$19.7M
2013 Q2
48 quarters
AEM icon
183
Agnico Eagle Mines
AEM
$95.7B
$73.3M 0.14%
616,728
-232
-0% -$26.9K
2018 Q4
26 quarters
ICE icon
184
Intercontinental Exchange
ICE
$87.7B
$73M 0.14%
397,693
-11,440
-3% -$1.97M
2013 Q2
48 quarters
DLTR icon
185
Dollar Tree
DLTR
$22.3B
$72.9M 0.14%
735,915
-6,961
-0.9% -$601K
2013 Q2
48 quarters
MA icon
186
Mastercard
MA
$516B
$72.8M 0.14%
129,537
-2,227
-2% -$1.23M
2013 Q2
48 quarters
BIDU icon
187
Baidu
BIDU
$29B
$72.5M 0.14%
845,595
-272,830
-24% -$23.5M
2018 Q2
28 quarters
CMG icon
188
Chipotle Mexican Grill
CMG
$40B
$72M 0.14%
1,282,451
-63,693
-5% -$3.24M
2013 Q2
48 quarters
PG icon
189
Procter & Gamble
PG
$351B
$71.7M 0.14%
450,347
-11,292
-2% -$1.84M
2013 Q2
48 quarters
FOXA icon
190
Fox Class A
FOXA
$26.3B
$71.7M 0.14%
1,280,317
+24,726
+2% +$1.3M
2024 Q3
3 quarters
JXN icon
191
Jackson Financial
JXN
$8.79B
$71.3M 0.13%
802,941
-134,631
-14% -$10.9M
2022 Q2
12 quarters
CM icon
192
Canadian Imperial Bank of Commerce
CM
$99.1B
$71.2M 0.13%
1,005,916
+17,517
+2% +$1.13M
2013 Q2
48 quarters
QTWO icon
193
Q2 Holdings
QTWO
$3.65B
$69.9M 0.13%
747,145
+207
+0% +$17.5K
2014 Q2
44 quarters
RGA icon
194
Reinsurance Group of America
RGA
$16.7B
$69.2M 0.13%
349,111
-93,131
-21% -$18.2M
2013 Q2
48 quarters
ORLY icon
195
O'Reilly Automotive
ORLY
$69.9B
$68.8M 0.13%
763,385
-47,410
-6% -$4.32M
2013 Q2
48 quarters
QXO icon
196
QXO Inc
QXO
$11.2B
$68.5M 0.13%
3,178,100
– –
2024 Q4
2 quarters
DEO icon
197
Diageo
DEO
$48.2B
$68.3M 0.13%
677,669
+46,196
+7% +$5.01M
2024 Q2
4 quarters
ARGX icon
198
argenx
ARGX
$51.9B
$68.2M 0.13%
123,659
+14,714
+14% +$8.54M
2017 Q2
32 quarters
WAB icon
199
Wabtec
WAB
$48.2B
$68M 0.13%
324,735
-1,182
-0.4% -$227K
2013 Q2
48 quarters
PLNT icon
200
Planet Fitness
PLNT
$3.62B
$67.9M 0.13%
622,392
-37,207
-6% -$3.73M
2015 Q3
39 quarters

Similar funds

Federated Hermes's Q2 2025 Portfolio in Review

As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.

  • Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
  • Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
  • Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
  • Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
  • Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
  • Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
  • Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.